CAMBRIDGE, Mass., Feb. 6, 2018 — DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, a digital health solutions company, today announced that the rHEALTH technology is the subject of a partnership with the National Aeronautics and Space Administration (NASA) and the United States Air Force (USAF). This is done via Phase IIE and III contracts associated with the Small Business Innovation Research (SBIR) and Small Technology Transfer (STTR) Programs.
“We are excited to continue work with NASA and the USAF to implement our unique diagnostic and monitoring technology and the use of the rHEALTH system,” stated Dr. Eugene Chan, President and CEO.
The collaboration will focus on advancing portable, wireless monitoring devices, including the rHEALTH small volume blood analyzer and the SKYE Sensor vitals monitor for astronaut and airmen-related applications.
rHEALTH is an innovative digital health solutions company focused on creating integrated technologies that fundamentally change how we care for our health. rHEALTH’s innovations consists of the rHEALTH diagnostic platform, which enables diverse laboratory test classes in a single small volume blood sample intended as a point-of-care solution, the SKYE Sensor, a wireless wearable providing comprehensive real-time vitals monitoring and CHAS, a user-friendly mobile application. For more information, visit www.rhealth.com.
About DNA Medicine Institute
DNA Medicine Institute (DMI) is a biomedical incubator focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Its work is supported by NASA, USAF, National Institutes of Health, and the Bill & Melinda Gates Foundation. DMI leverages substantial expertise in interdisciplinary science and engineering to solve challenging problems. For more information, visit www.dnamedinstitute.com.
Media Contact: Lillian Li, rHEALTH LLC, (617) 913-7630, firstname.lastname@example.org